dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs1805123
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr7:150948446 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- T>A / T>C / T>G
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
G=0.221147 (72786/329130, ALFA)G=0.154660 (40937/264690, TOPMED)G=0.187149 (21515/114962, ExAC) (+ 21 more)
- Clinical Significance
- Reported in ClinVar
- Gene : Consequence
- KCNH2 : Missense Variant
- Publications
- 50 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
Population | Group | Sample Size | Ref Allele | Alt Allele | Ref HMOZ | Alt HMOZ | HTRZ | HWEP |
---|---|---|---|---|---|---|---|---|
Total | Global | 329346 | T=0.778877 | A=0.000000, C=0.000009, G=0.221114 | 0.611071 | 0.053307 | 0.335623 | 32 |
European | Sub | 283744 | T=0.763318 | A=0.000000, C=0.000004, G=0.236678 | 0.584566 | 0.057926 | 0.357508 | 9 |
African | Sub | 11472 | T=0.95990 | A=0.00000, C=0.00000, G=0.04010 | 0.922768 | 0.002964 | 0.074268 | 4 |
African Others | Sub | 410 | T=0.998 | A=0.000, C=0.000, G=0.002 | 0.995122 | 0.0 | 0.004878 | 0 |
African American | Sub | 11062 | T=0.95851 | A=0.00000, C=0.00000, G=0.04149 | 0.920087 | 0.003074 | 0.07684 | 4 |
Asian | Sub | 6872 | T=0.9518 | A=0.0000, C=0.0000, G=0.0482 | 0.905704 | 0.002037 | 0.092258 | 0 |
East Asian | Sub | 4914 | T=0.9512 | A=0.0000, C=0.0000, G=0.0488 | 0.904762 | 0.002442 | 0.092796 | 0 |
Other Asian | Sub | 1958 | T=0.9535 | A=0.0000, C=0.0000, G=0.0465 | 0.908069 | 0.001021 | 0.090909 | 0 |
Latin American 1 | Sub | 1022 | T=0.8425 | A=0.0000, C=0.0000, G=0.1575 | 0.708415 | 0.023483 | 0.268102 | 0 |
Latin American 2 | Sub | 2996 | T=0.8742 | A=0.0000, C=0.0000, G=0.1258 | 0.76502 | 0.016689 | 0.218291 | 0 |
South Asian | Sub | 5188 | T=0.8086 | A=0.0000, C=0.0000, G=0.1914 | 0.656901 | 0.039707 | 0.303392 | 1 |
Other | Sub | 18052 | T=0.81459 | A=0.00000, C=0.00011, G=0.18530 | 0.673205 | 0.043883 | 0.282912 | 20 |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
DownloadStudy | Population | Group | Sample Size | Ref Allele | Alt Allele |
---|---|---|---|---|---|
Allele Frequency Aggregator | Total | Global | 329130 | T=0.778844 | A=0.000000, C=0.000009, G=0.221147 |
Allele Frequency Aggregator | European | Sub | 283564 | T=0.763292 | A=0.000000, C=0.000004, G=0.236705 |
Allele Frequency Aggregator | Other | Sub | 18030 | T=0.81442 | A=0.00000, C=0.00011, G=0.18547 |
Allele Frequency Aggregator | African | Sub | 11458 | T=0.95994 | A=0.00000, C=0.00000, G=0.04006 |
Allele Frequency Aggregator | Asian | Sub | 6872 | T=0.9518 | A=0.0000, C=0.0000, G=0.0482 |
Allele Frequency Aggregator | South Asian | Sub | 5188 | T=0.8086 | A=0.0000, C=0.0000, G=0.1914 |
Allele Frequency Aggregator | Latin American 2 | Sub | 2996 | T=0.8742 | A=0.0000, C=0.0000, G=0.1258 |
Allele Frequency Aggregator | Latin American 1 | Sub | 1022 | T=0.8425 | A=0.0000, C=0.0000, G=0.1575 |
TopMed | Global | Study-wide | 264690 | T=0.845340 | G=0.154660 |
ExAC | Global | Study-wide | 114962 | T=0.812851 | G=0.187149 |
ExAC | Europe | Sub | 69484 | T=0.77019 | G=0.22981 |
ExAC | Asian | Sub | 24328 | T=0.84360 | G=0.15640 |
ExAC | American | Sub | 11192 | T=0.89707 | G=0.10293 |
ExAC | African | Sub | 9104 | T=0.9561 | G=0.0439 |
ExAC | Other | Sub | 854 | T=0.778 | G=0.222 |
gnomAD - Genomes | Global | Study-wide | 110064 | T=0.797000 | G=0.203000 |
gnomAD - Genomes | European | Sub | 61784 | T=0.72153 | G=0.27847 |
gnomAD - Genomes | African | Sub | 30386 | T=0.94073 | G=0.05927 |
gnomAD - Genomes | American | Sub | 10708 | T=0.79436 | G=0.20564 |
gnomAD - Genomes | Ashkenazi Jewish | Sub | 2822 | T=0.7690 | G=0.2310 |
gnomAD - Genomes | East Asian | Sub | 2700 | T=0.9478 | G=0.0522 |
gnomAD - Genomes | Other | Sub | 1664 | T=0.7945 | G=0.2055 |
The PAGE Study | Global | Study-wide | 78692 | T=0.90899 | G=0.09101 |
The PAGE Study | AfricanAmerican | Sub | 32510 | T=0.95152 | G=0.04848 |
The PAGE Study | Mexican | Sub | 10808 | T=0.87713 | G=0.12287 |
The PAGE Study | Asian | Sub | 8316 | T=0.9576 | G=0.0424 |
The PAGE Study | PuertoRican | Sub | 7918 | T=0.8481 | G=0.1519 |
The PAGE Study | NativeHawaiian | Sub | 4534 | T=0.9255 | G=0.0745 |
The PAGE Study | Cuban | Sub | 4230 | T=0.7823 | G=0.2177 |
The PAGE Study | Dominican | Sub | 3828 | T=0.8676 | G=0.1324 |
The PAGE Study | CentralAmerican | Sub | 2450 | T=0.8853 | G=0.1147 |
The PAGE Study | SouthAmerican | Sub | 1982 | T=0.8597 | G=0.1403 |
The PAGE Study | NativeAmerican | Sub | 1260 | T=0.8381 | G=0.1619 |
The PAGE Study | SouthAsian | Sub | 856 | T=0.798 | G=0.202 |
14KJPN | JAPANESE | Study-wide | 28254 | T=0.96043 | G=0.03957 |
8.3KJPN | JAPANESE | Study-wide | 16756 | T=0.96013 | G=0.03987 |
GO Exome Sequencing Project | Global | Study-wide | 13006 | T=0.83092 | G=0.16908 |
GO Exome Sequencing Project | European American | Sub | 8600 | T=0.7674 | G=0.2326 |
GO Exome Sequencing Project | African American | Sub | 4406 | T=0.9548 | G=0.0452 |
1000Genomes_30x | Global | Study-wide | 6404 | T=0.8679 | G=0.1321 |
1000Genomes_30x | African | Sub | 1786 | T=0.9927 | G=0.0073 |
1000Genomes_30x | Europe | Sub | 1266 | T=0.7480 | G=0.2520 |
1000Genomes_30x | South Asian | Sub | 1202 | T=0.7512 | G=0.2488 |
1000Genomes_30x | East Asian | Sub | 1170 | T=0.9487 | G=0.0513 |
1000Genomes_30x | American | Sub | 980 | T=0.842 | G=0.158 |
1000Genomes | Global | Study-wide | 5008 | T=0.8638 | G=0.1362 |
1000Genomes | African | Sub | 1322 | T=0.9932 | G=0.0068 |
1000Genomes | East Asian | Sub | 1008 | T=0.9464 | G=0.0536 |
1000Genomes | Europe | Sub | 1006 | T=0.7465 | G=0.2535 |
1000Genomes | South Asian | Sub | 978 | T=0.748 | G=0.252 |
1000Genomes | American | Sub | 694 | T=0.830 | G=0.170 |
Genetic variation in the Estonian population | Estonian | Study-wide | 4480 | T=0.8402 | G=0.1598 |
The Avon Longitudinal Study of Parents and Children | PARENT AND CHILD COHORT | Study-wide | 3854 | T=0.7579 | G=0.2421 |
UK 10K study - Twins | TWIN COHORT | Study-wide | 3708 | T=0.7527 | G=0.2473 |
KOREAN population from KRGDB | KOREAN | Study-wide | 2902 | T=0.9511 | G=0.0489 |
HapMap | Global | Study-wide | 1780 | T=0.8876 | G=0.1124 |
HapMap | American | Sub | 770 | T=0.831 | G=0.169 |
HapMap | African | Sub | 582 | T=0.976 | G=0.024 |
HapMap | Asian | Sub | 254 | T=0.969 | G=0.031 |
HapMap | Europe | Sub | 174 | T=0.724 | G=0.276 |
CNV burdens in cranial meningiomas | Global | Study-wide | 792 | T=0.956 | G=0.044 |
CNV burdens in cranial meningiomas | CRM | Sub | 792 | T=0.956 | G=0.044 |
PharmGKB Aggregated | Global | Study-wide | 640 | T=0.102 | G=0.898 |
PharmGKB Aggregated | PA129994867 | Sub | 640 | T=0.102 | G=0.898 |
Northern Sweden | ACPOP | Study-wide | 600 | T=0.785 | G=0.215 |
Medical Genome Project healthy controls from Spanish population | Spanish controls | Study-wide | 534 | T=0.790 | G=0.210 |
FINRISK | Finnish from FINRISK project | Study-wide | 296 | T=0.824 | G=0.176 |
Qatari | Global | Study-wide | 216 | T=0.833 | G=0.167 |
SGDP_PRJ | Global | Study-wide | 118 | T=0.466 | G=0.534 |
The Danish reference pan genome | Danish | Study-wide | 40 | T=0.60 | G=0.40 |
Siberian | Global | Study-wide | 24 | T=0.46 | G=0.54 |
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Sequence name | Change |
---|---|
GRCh38.p14 chr 7 | NC_000007.14:g.150948446T>A |
GRCh38.p14 chr 7 | NC_000007.14:g.150948446T>C |
GRCh38.p14 chr 7 | NC_000007.14:g.150948446T>G |
GRCh37.p13 chr 7 | NC_000007.13:g.150645534T>A |
GRCh37.p13 chr 7 | NC_000007.13:g.150645534T>C |
GRCh37.p13 chr 7 | NC_000007.13:g.150645534T>G |
KCNH2 RefSeqGene (LRG_288) | NG_008916.1:g.34481A>T |
KCNH2 RefSeqGene (LRG_288) | NG_008916.1:g.34481A>G |
KCNH2 RefSeqGene (LRG_288) | NG_008916.1:g.34481A>C |
Molecule type | Change | Amino acid[Codon] | SO Term |
---|---|---|---|
KCNH2 transcript variant 4 | NM_001204798.2:c. | N/A | Genic Downstream Transcript Variant |
KCNH2 transcript variant 2 | NM_172056.2:c. | N/A | Genic Downstream Transcript Variant |
KCNH2 transcript variant 1 | NM_000238.4:c.2690A>T | K [AAG] > M [ATG] | Coding Sequence Variant |
voltage-gated inwardly rectifying potassium channel KCNH2 isoform a | NP_000229.1:p.Lys897Met | K (Lys) > M (Met) | Missense Variant |
KCNH2 transcript variant 1 | NM_000238.4:c.2690A>G | K [AAG] > R [AGG] | Coding Sequence Variant |
voltage-gated inwardly rectifying potassium channel KCNH2 isoform a | NP_000229.1:p.Lys897Arg | K (Lys) > R (Arg) | Missense Variant |
KCNH2 transcript variant 1 | NM_000238.4:c.2690A>C | K [AAG] > T [ACG] | Coding Sequence Variant |
voltage-gated inwardly rectifying potassium channel KCNH2 isoform a | NP_000229.1:p.Lys897Thr | K (Lys) > T (Thr) | Missense Variant |
KCNH2 transcript variant 3 | NM_172057.3:c.1670A>T | K [AAG] > M [ATG] | Coding Sequence Variant |
voltage-gated inwardly rectifying potassium channel KCNH2 isoform c | NP_742054.1:p.Lys557Met | K (Lys) > M (Met) | Missense Variant |
KCNH2 transcript variant 3 | NM_172057.3:c.1670A>G | K [AAG] > R [AGG] | Coding Sequence Variant |
voltage-gated inwardly rectifying potassium channel KCNH2 isoform c | NP_742054.1:p.Lys557Arg | K (Lys) > R (Arg) | Missense Variant |
KCNH2 transcript variant 3 | NM_172057.3:c.1670A>C | K [AAG] > T [ACG] | Coding Sequence Variant |
voltage-gated inwardly rectifying potassium channel KCNH2 isoform c | NP_742054.1:p.Lys557Thr | K (Lys) > T (Thr) | Missense Variant |
KCNH2 transcript variant X1 | XM_047420348.1:c.2768A>T | K [AAG] > M [ATG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X1 | XP_047276304.1:p.Lys923Met | K (Lys) > M (Met) | Missense Variant |
KCNH2 transcript variant X1 | XM_047420348.1:c.2768A>G | K [AAG] > R [AGG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X1 | XP_047276304.1:p.Lys923Arg | K (Lys) > R (Arg) | Missense Variant |
KCNH2 transcript variant X1 | XM_047420348.1:c.2768A>C | K [AAG] > T [ACG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X1 | XP_047276304.1:p.Lys923Thr | K (Lys) > T (Thr) | Missense Variant |
KCNH2 transcript variant X2 | XM_017012195.2:c.2540A>T | K [AAG] > M [ATG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X2 | XP_016867684.1:p.Lys847Met | K (Lys) > M (Met) | Missense Variant |
KCNH2 transcript variant X2 | XM_017012195.2:c.2540A>G | K [AAG] > R [AGG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X2 | XP_016867684.1:p.Lys847Arg | K (Lys) > R (Arg) | Missense Variant |
KCNH2 transcript variant X2 | XM_017012195.2:c.2540A>C | K [AAG] > T [ACG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X2 | XP_016867684.1:p.Lys847Thr | K (Lys) > T (Thr) | Missense Variant |
KCNH2 transcript variant X3 | XM_017012196.2:c.2513A>T | K [AAG] > M [ATG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X3 | XP_016867685.1:p.Lys838Met | K (Lys) > M (Met) | Missense Variant |
KCNH2 transcript variant X3 | XM_017012196.2:c.2513A>G | K [AAG] > R [AGG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X3 | XP_016867685.1:p.Lys838Arg | K (Lys) > R (Arg) | Missense Variant |
KCNH2 transcript variant X3 | XM_017012196.2:c.2513A>C | K [AAG] > T [ACG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X3 | XP_016867685.1:p.Lys838Thr | K (Lys) > T (Thr) | Missense Variant |
KCNH2 transcript variant X4 | XM_011516185.3:c.2390A>T | K [AAG] > M [ATG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X4 | XP_011514487.1:p.Lys797Met | K (Lys) > M (Met) | Missense Variant |
KCNH2 transcript variant X4 | XM_011516185.3:c.2390A>G | K [AAG] > R [AGG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X4 | XP_011514487.1:p.Lys797Arg | K (Lys) > R (Arg) | Missense Variant |
KCNH2 transcript variant X4 | XM_011516185.3:c.2390A>C | K [AAG] > T [ACG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X4 | XP_011514487.1:p.Lys797Thr | K (Lys) > T (Thr) | Missense Variant |
KCNH2 transcript variant X5 | XM_047420349.1:c.2768A>T | K [AAG] > M [ATG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X5 | XP_047276305.1:p.Lys923Met | K (Lys) > M (Met) | Missense Variant |
KCNH2 transcript variant X5 | XM_047420349.1:c.2768A>G | K [AAG] > R [AGG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X5 | XP_047276305.1:p.Lys923Arg | K (Lys) > R (Arg) | Missense Variant |
KCNH2 transcript variant X5 | XM_047420349.1:c.2768A>C | K [AAG] > T [ACG] | Coding Sequence Variant |
potassium voltage-gated channel subfamily H member 2 isoform X5 | XP_047276305.1:p.Lys923Thr | K (Lys) > T (Thr) | Missense Variant |
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
ClinVar Accession | Disease Names | Clinical Significance |
---|---|---|
RCV000181882.4 | not provided | Uncertain-Significance |
RCV001842831.2 | Cardiac arrhythmia | Uncertain-Significance |
ClinVar Accession | Disease Names | Clinical Significance |
---|---|---|
RCV000058152.13 | not provided | Benign |
RCV000171815.3 | Atrial fibrillation | Benign |
RCV000223864.13 | not specified | Benign |
RCV000249181.2 | Cardiovascular phenotype | Benign |
RCV000276195.6 | Long QT syndrome | Benign |
RCV001095232.5 | Long QT syndrome 2 | Benign |
RCV001841716.2 | Cardiac arrhythmia | Benign |
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
Placement | T= | A | C | G |
---|---|---|---|---|
GRCh38.p14 chr 7 | NC_000007.14:g.150948446= | NC_000007.14:g.150948446T>A | NC_000007.14:g.150948446T>C | NC_000007.14:g.150948446T>G |
GRCh37.p13 chr 7 | NC_000007.13:g.150645534= | NC_000007.13:g.150645534T>A | NC_000007.13:g.150645534T>C | NC_000007.13:g.150645534T>G |
KCNH2 RefSeqGene (LRG_288) | NG_008916.1:g.34481= | NG_008916.1:g.34481A>T | NG_008916.1:g.34481A>G | NG_008916.1:g.34481A>C |
KCNH2 transcript variant 1 | NM_000238.4:c.2690= | NM_000238.4:c.2690A>T | NM_000238.4:c.2690A>G | NM_000238.4:c.2690A>C |
KCNH2 transcript variant 1 | NM_000238.3:c.2690= | NM_000238.3:c.2690A>T | NM_000238.3:c.2690A>G | NM_000238.3:c.2690A>C |
KCNH2 transcript variant 3 | NM_172057.3:c.1670= | NM_172057.3:c.1670A>T | NM_172057.3:c.1670A>G | NM_172057.3:c.1670A>C |
KCNH2 transcript variant 3 | NM_172057.2:c.1670= | NM_172057.2:c.1670A>T | NM_172057.2:c.1670A>G | NM_172057.2:c.1670A>C |
KCNH2 transcript variant 9 | NR_176254.1:n.3098= | NR_176254.1:n.3098A>T | NR_176254.1:n.3098A>G | NR_176254.1:n.3098A>C |
KCNH2 transcript variant 5 | NM_001406753.1:c.2402= | NM_001406753.1:c.2402A>T | NM_001406753.1:c.2402A>G | NM_001406753.1:c.2402A>C |
KCNH2 transcript variant 10 | NR_176255.1:n.1971= | NR_176255.1:n.1971A>T | NR_176255.1:n.1971A>G | NR_176255.1:n.1971A>C |
KCNH2 transcript variant X4 | XM_011516185.3:c.2390= | XM_011516185.3:c.2390A>T | XM_011516185.3:c.2390A>G | XM_011516185.3:c.2390A>C |
KCNH2 transcript variant X2 | XM_011516185.2:c.2390= | XM_011516185.2:c.2390A>T | XM_011516185.2:c.2390A>G | XM_011516185.2:c.2390A>C |
KCNH2 transcript variant X1 | XM_011516185.1:c.2390= | XM_011516185.1:c.2390A>T | XM_011516185.1:c.2390A>G | XM_011516185.1:c.2390A>C |
KCNH2 transcript variant X2 | XM_017012195.2:c.2540= | XM_017012195.2:c.2540A>T | XM_017012195.2:c.2540A>G | XM_017012195.2:c.2540A>C |
KCNH2 transcript variant X1 | XM_017012195.1:c.2540= | XM_017012195.1:c.2540A>T | XM_017012195.1:c.2540A>G | XM_017012195.1:c.2540A>C |
KCNH2 transcript variant X3 | XM_017012196.2:c.2513= | XM_017012196.2:c.2513A>T | XM_017012196.2:c.2513A>G | XM_017012196.2:c.2513A>C |
KCNH2 transcript variant X3 | XM_017012196.1:c.2513= | XM_017012196.1:c.2513A>T | XM_017012196.1:c.2513A>G | XM_017012196.1:c.2513A>C |
KCNH2 transcript variant X1 | XM_047420348.1:c.2768= | XM_047420348.1:c.2768A>T | XM_047420348.1:c.2768A>G | XM_047420348.1:c.2768A>C |
KCNH2 transcript variant X5 | XM_047420349.1:c.2768= | XM_047420349.1:c.2768A>T | XM_047420349.1:c.2768A>G | XM_047420349.1:c.2768A>C |
voltage-gated inwardly rectifying potassium channel KCNH2 isoform a | NP_000229.1:p.Lys897= | NP_000229.1:p.Lys897Met | NP_000229.1:p.Lys897Arg | NP_000229.1:p.Lys897Thr |
voltage-gated inwardly rectifying potassium channel KCNH2 isoform c | NP_742054.1:p.Lys557= | NP_742054.1:p.Lys557Met | NP_742054.1:p.Lys557Arg | NP_742054.1:p.Lys557Thr |
potassium voltage-gated channel subfamily H member 2 isoform X4 | XP_011514487.1:p.Lys797= | XP_011514487.1:p.Lys797Met | XP_011514487.1:p.Lys797Arg | XP_011514487.1:p.Lys797Thr |
potassium voltage-gated channel subfamily H member 2 isoform X2 | XP_016867684.1:p.Lys847= | XP_016867684.1:p.Lys847Met | XP_016867684.1:p.Lys847Arg | XP_016867684.1:p.Lys847Thr |
potassium voltage-gated channel subfamily H member 2 isoform X3 | XP_016867685.1:p.Lys838= | XP_016867685.1:p.Lys838Met | XP_016867685.1:p.Lys838Arg | XP_016867685.1:p.Lys838Thr |
potassium voltage-gated channel subfamily H member 2 isoform X1 | XP_047276304.1:p.Lys923= | XP_047276304.1:p.Lys923Met | XP_047276304.1:p.Lys923Arg | XP_047276304.1:p.Lys923Thr |
potassium voltage-gated channel subfamily H member 2 isoform X5 | XP_047276305.1:p.Lys923= | XP_047276305.1:p.Lys923Met | XP_047276305.1:p.Lys923Arg | XP_047276305.1:p.Lys923Thr |
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
No | Submitter | Submission ID | Date (Build) |
---|---|---|---|
1 | SC_JCM | ss4181602 | Nov 05, 2001 (102) |
2 | DRSHEAD | ss9807249 | Aug 27, 2003 (123) |
3 | PHARMGKB_PAT | ss69364196 | May 18, 2007 (127) |
4 | ILLUMINA | ss74912009 | Dec 07, 2007 (129) |
5 | SI_EXO | ss76900126 | Dec 07, 2007 (129) |
6 | KRIBB_YJKIM | ss119404135 | Dec 01, 2009 (131) |
7 | ILLUMINA | ss153737242 | Dec 01, 2009 (131) |
8 | ILLUMINA | ss159329902 | Dec 01, 2009 (131) |
9 | ILLUMINA | ss160463284 | Dec 01, 2009 (131) |
10 | ILLUMINA | ss172926528 | Jul 04, 2010 (132) |
11 | 1000GENOMES | ss234225278 | Jul 15, 2010 (132) |
12 | ILLUMINA | ss244285189 | Jul 04, 2010 (132) |
13 | NHLBI-ESP | ss342250053 | May 09, 2011 (134) |
14 | ILLUMINA | ss410872566 | Sep 17, 2011 (135) |
15 | ILLUMINA | ss480301756 | May 04, 2012 (137) |
16 | ILLUMINA | ss480312837 | May 04, 2012 (137) |
17 | ILLUMINA | ss481068927 | Sep 08, 2015 (146) |
18 | ILLUMINA | ss484948672 | May 04, 2012 (137) |
19 | RBH_CV_BRU | ss487104648 | Mar 09, 2012 (136) |
20 | 1000GENOMES | ss490957305 | May 04, 2012 (137) |
21 | EXOME_CHIP | ss491408257 | May 04, 2012 (137) |
22 | CLINSEQ_SNP | ss491918104 | May 04, 2012 (137) |
23 | ILLUMINA | ss536992677 | Sep 08, 2015 (146) |
24 | SSMP | ss654813128 | Apr 25, 2013 (138) |
25 | ILLUMINA | ss778467902 | Sep 08, 2015 (146) |
26 | ILLUMINA | ss780866074 | Sep 08, 2015 (146) |
27 | ILLUMINA | ss782920643 | Sep 08, 2015 (146) |
28 | ILLUMINA | ss783550849 | Sep 08, 2015 (146) |
29 | ILLUMINA | ss783883651 | Sep 08, 2015 (146) |
30 | ILLUMINA | ss832175772 | Sep 08, 2015 (146) |
31 | ILLUMINA | ss832841911 | Jul 13, 2019 (153) |
32 | ILLUMINA | ss833923661 | Sep 08, 2015 (146) |
33 | EVA-GONL | ss984958336 | Aug 21, 2014 (142) |
34 | JMKIDD_LAB | ss1067494072 | Aug 21, 2014 (142) |
35 | 1000GENOMES | ss1327740856 | Aug 21, 2014 (142) |
36 | EVA_GENOME_DK | ss1582463292 | Apr 01, 2015 (144) |
37 | EVA_FINRISK | ss1584056161 | Apr 01, 2015 (144) |
38 | EVA_DECODE | ss1594548737 | Apr 01, 2015 (144) |
39 | EVA_UK10K_ALSPAC | ss1619533184 | Apr 01, 2015 (144) |
40 | EVA_UK10K_TWINSUK | ss1662527217 | Apr 01, 2015 (144) |
41 | EVA_EXAC | ss1689026134 | Apr 01, 2015 (144) |
42 | EVA_MGP | ss1711186136 | Apr 01, 2015 (144) |
43 | EVA_SVP | ss1712998339 | Apr 01, 2015 (144) |
44 | ILLUMINA | ss1752671886 | Sep 08, 2015 (146) |
45 | ILLUMINA | ss1752671887 | Sep 08, 2015 (146) |
46 | ILLUMINA | ss1917824218 | Feb 12, 2016 (147) |
47 | WEILL_CORNELL_DGM | ss1928221182 | Feb 12, 2016 (147) |
48 | CLINVAR | ss1939866510 | Oct 20, 2015 (146) |
49 | ILLUMINA | ss1946224983 | Feb 12, 2016 (147) |
50 | ILLUMINA | ss1959065739 | Feb 12, 2016 (147) |
51 | AMU | ss1966656833 | Feb 12, 2016 (147) |
52 | JJLAB | ss2024799568 | Sep 14, 2016 (149) |
53 | USC_VALOUEV | ss2153023196 | Dec 20, 2016 (150) |
54 | HUMAN_LONGEVITY | ss2299064995 | Dec 20, 2016 (150) |
55 | ILLUMINA | ss2634678732 | Nov 08, 2017 (151) |
56 | AFFY | ss2985425388 | Nov 08, 2017 (151) |
57 | AFFY | ss2986055656 | Nov 08, 2017 (151) |
58 | SWEGEN | ss3002295505 | Nov 08, 2017 (151) |
59 | ILLUMINA | ss3022794952 | Nov 08, 2017 (151) |
60 | BIOINF_KMB_FNS_UNIBA | ss3026188806 | Nov 08, 2017 (151) |
61 | CSHL | ss3347917529 | Nov 08, 2017 (151) |
62 | ILLUMINA | ss3629947394 | Oct 12, 2018 (152) |
63 | ILLUMINA | ss3629947395 | Oct 12, 2018 (152) |
64 | ILLUMINA | ss3632582026 | Oct 12, 2018 (152) |
65 | ILLUMINA | ss3633482843 | Oct 12, 2018 (152) |
66 | ILLUMINA | ss3634208721 | Oct 12, 2018 (152) |
67 | ILLUMINA | ss3635148765 | Oct 12, 2018 (152) |
68 | ILLUMINA | ss3635148766 | Oct 12, 2018 (152) |
69 | ILLUMINA | ss3635888012 | Oct 12, 2018 (152) |
70 | ILLUMINA | ss3636883641 | Oct 12, 2018 (152) |
71 | ILLUMINA | ss3637641080 | Oct 12, 2018 (152) |
72 | ILLUMINA | ss3638732243 | Oct 12, 2018 (152) |
73 | ILLUMINA | ss3640856055 | Oct 12, 2018 (152) |
74 | ILLUMINA | ss3640856056 | Oct 12, 2018 (152) |
75 | ILLUMINA | ss3643665351 | Oct 12, 2018 (152) |
76 | ILLUMINA | ss3644958139 | Oct 12, 2018 (152) |
77 | OMUKHERJEE_ADBS | ss3646366472 | Oct 12, 2018 (152) |
78 | ILLUMINA | ss3653331083 | Oct 12, 2018 (152) |
79 | ILLUMINA | ss3654186853 | Oct 12, 2018 (152) |
80 | EGCUT_WGS | ss3670034293 | Jul 13, 2019 (153) |
81 | EVA_DECODE | ss3720992422 | Jul 13, 2019 (153) |
82 | ILLUMINA | ss3726494921 | Jul 13, 2019 (153) |
83 | ACPOP | ss3735203030 | Jul 13, 2019 (153) |
84 | ILLUMINA | ss3744575411 | Jul 13, 2019 (153) |
85 | ILLUMINA | ss3745448704 | Jul 13, 2019 (153) |
86 | ILLUMINA | ss3745448705 | Jul 13, 2019 (153) |
87 | EVA | ss3767344120 | Jul 13, 2019 (153) |
88 | PAGE_CC | ss3771408605 | Jul 13, 2019 (153) |
89 | ILLUMINA | ss3772941390 | Jul 13, 2019 (153) |
90 | ILLUMINA | ss3772941391 | Jul 13, 2019 (153) |
91 | PACBIO | ss3786002341 | Jul 13, 2019 (153) |
92 | PACBIO | ss3791274270 | Jul 13, 2019 (153) |
93 | PACBIO | ss3796154583 | Jul 13, 2019 (153) |
94 | KHV_HUMAN_GENOMES | ss3810512819 | Jul 13, 2019 (153) |
95 | EVA | ss3824334073 | Apr 26, 2020 (154) |
96 | EVA | ss3825732499 | Apr 26, 2020 (154) |
97 | EVA | ss3830897642 | Apr 26, 2020 (154) |
98 | EVA | ss3838949156 | Apr 26, 2020 (154) |
99 | EVA | ss3844406742 | Apr 26, 2020 (154) |
100 | SGDP_PRJ | ss3868724860 | Apr 26, 2020 (154) |
101 | KRGDB | ss3916116988 | Apr 26, 2020 (154) |
102 | KOGIC | ss3962873600 | Apr 26, 2020 (154) |
103 | KOGIC | ss3962873601 | Apr 26, 2020 (154) |
104 | FSA-LAB | ss3984386891 | Apr 26, 2021 (155) |
105 | FSA-LAB | ss3984386892 | Apr 26, 2021 (155) |
106 | EVA | ss3984597499 | Apr 26, 2021 (155) |
107 | EVA | ss3986407667 | Apr 26, 2021 (155) |
108 | GNOMAD | ss4175774869 | Apr 26, 2021 (155) |
109 | TOPMED | ss4768975375 | Apr 26, 2021 (155) |
110 | TOMMO_GENOMICS | ss5186284180 | Apr 26, 2021 (155) |
111 | EVA | ss5237039071 | Apr 26, 2021 (155) |
112 | EVA | ss5237199192 | Apr 26, 2021 (155) |
113 | EVA | ss5237432073 | Apr 26, 2021 (155) |
114 | EVA | ss5237650421 | Oct 13, 2022 (156) |
115 | 1000G_HIGH_COVERAGE | ss5275288308 | Oct 13, 2022 (156) |
116 | TRAN_CS_UWATERLOO | ss5314421791 | Oct 13, 2022 (156) |
117 | EVA | ss5315289674 | Oct 13, 2022 (156) |
118 | EVA | ss5377761595 | Oct 13, 2022 (156) |
119 | HUGCELL_USP | ss5472099033 | Oct 13, 2022 (156) |
120 | EVA | ss5509184676 | Oct 13, 2022 (156) |
121 | 1000G_HIGH_COVERAGE | ss5564716629 | Oct 13, 2022 (156) |
122 | EVA | ss5624173709 | Oct 13, 2022 (156) |
123 | SANFORD_IMAGENETICS | ss5624679174 | Oct 13, 2022 (156) |
124 | SANFORD_IMAGENETICS | ss5644299745 | Oct 13, 2022 (156) |
125 | TOMMO_GENOMICS | ss5727501126 | Oct 13, 2022 (156) |
126 | EVA | ss5799741007 | Oct 13, 2022 (156) |
127 | EVA | ss5800058738 | Oct 13, 2022 (156) |
128 | EVA | ss5800143744 | Oct 13, 2022 (156) |
129 | YY_MCH | ss5809231947 | Oct 13, 2022 (156) |
130 | EVA | ss5823734831 | Oct 13, 2022 (156) |
131 | EVA | ss5848697353 | Oct 13, 2022 (156) |
132 | EVA | ss5856157498 | Oct 13, 2022 (156) |
133 | EVA | ss5861489259 | Oct 13, 2022 (156) |
134 | EVA | ss5973500221 | Oct 13, 2022 (156) |
135 | EVA | ss5979846286 | Oct 13, 2022 (156) |
136 | EVA | ss5980471971 | Oct 13, 2022 (156) |
137 | 1000Genomes | NC_000007.13 - 150645534 | Oct 12, 2018 (152) |
138 | 1000Genomes_30x | NC_000007.14 - 150948446 | Oct 13, 2022 (156) |
139 | The Avon Longitudinal Study of Parents and Children | NC_000007.13 - 150645534 | Oct 12, 2018 (152) |
140 | Genetic variation in the Estonian population | NC_000007.13 - 150645534 | Oct 12, 2018 (152) |
141 | ExAC | NC_000007.13 - 150645534 | Oct 12, 2018 (152) |
142 | FINRISK | NC_000007.13 - 150645534 | Apr 26, 2020 (154) |
143 | The Danish reference pan genome | NC_000007.13 - 150645534 | Apr 26, 2020 (154) |
144 | gnomAD - Genomes | NC_000007.14 - 150948446 | Apr 26, 2021 (155) |
145 |
gnomAD - Exomes
Submission ignored due to conflicting rows: |
- | Jul 13, 2019 (153) |
146 |
gnomAD - Exomes
Submission ignored due to conflicting rows: |
- | Jul 13, 2019 (153) |
147 | GO Exome Sequencing Project | NC_000007.13 - 150645534 | Oct 12, 2018 (152) |
148 | HapMap | NC_000007.14 - 150948446 | Apr 26, 2020 (154) |
149 | KOREAN population from KRGDB | NC_000007.13 - 150645534 | Apr 26, 2020 (154) |
150 |
Korean Genome Project
Submission ignored due to conflicting rows: |
- | Apr 26, 2020 (154) |
151 |
Korean Genome Project
Submission ignored due to conflicting rows: |
- | Apr 26, 2020 (154) |
152 | Medical Genome Project healthy controls from Spanish population | NC_000007.13 - 150645534 | Apr 26, 2020 (154) |
153 | Northern Sweden | NC_000007.13 - 150645534 | Jul 13, 2019 (153) |
154 | The PAGE Study | NC_000007.14 - 150948446 | Jul 13, 2019 (153) |
155 | CNV burdens in cranial meningiomas | NC_000007.13 - 150645534 | Apr 26, 2021 (155) |
156 | PharmGKB Aggregated | NC_000007.14 - 150948446 | Apr 26, 2020 (154) |
157 | Qatari | NC_000007.13 - 150645534 | Apr 26, 2020 (154) |
158 | SGDP_PRJ | NC_000007.13 - 150645534 | Apr 26, 2020 (154) |
159 | Siberian | NC_000007.13 - 150645534 | Apr 26, 2020 (154) |
160 | 8.3KJPN | NC_000007.13 - 150645534 | Apr 26, 2021 (155) |
161 | 14KJPN | NC_000007.14 - 150948446 | Oct 13, 2022 (156) |
162 | TopMed | NC_000007.14 - 150948446 | Apr 26, 2021 (155) |
163 | UK 10K study - Twins | NC_000007.13 - 150645534 | Oct 12, 2018 (152) |
164 | ALFA | NC_000007.14 - 150948446 | Apr 26, 2021 (155) |
165 | ClinVar | RCV000058152.13 | Oct 13, 2022 (156) |
166 | ClinVar | RCV000171815.3 | Oct 13, 2022 (156) |
167 | ClinVar | RCV000181882.4 | Oct 13, 2022 (156) |
168 | ClinVar | RCV000223864.13 | Oct 13, 2022 (156) |
169 | ClinVar | RCV000249181.2 | Oct 13, 2022 (156) |
170 | ClinVar | RCV000276195.6 | Oct 13, 2022 (156) |
171 | ClinVar | RCV001095232.5 | Oct 13, 2022 (156) |
172 | ClinVar | RCV001841716.2 | Oct 13, 2022 (156) |
173 | ClinVar | RCV001842831.2 | Oct 13, 2022 (156) |
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
---|---|---|---|
RCV000181882.4, RCV001842831.2, 10051261921, ss1939866510 | NC_000007.14:150948445:T:A | NC_000007.14:150948445:T:A | (self) |
NC_000007.13:150645533:T:C | NC_000007.14:150948445:T:C | (self) | |
10051261921, ss3962873601 | NC_000007.14:150948445:T:C | NC_000007.14:150948445:T:C | (self) |
ss480301756, ss491918104, ss1594548737, ss1712998339, ss3643665351 | NC_000007.12:150276466:T:G | NC_000007.14:150948445:T:G | (self) |
39806884, 22150859, 15772541, 9114318, 52622, 8628230, 791940, 23294382, 301896, 8487895, 146932, 10263112, 20741840, 5539550, 44253487, 22150859, ss234225278, ss342250053, ss480312837, ss481068927, ss484948672, ss490957305, ss491408257, ss536992677, ss654813128, ss778467902, ss780866074, ss782920643, ss783550849, ss783883651, ss832175772, ss832841911, ss833923661, ss984958336, ss1067494072, ss1327740856, ss1582463292, ss1584056161, ss1619533184, ss1662527217, ss1689026134, ss1711186136, ss1752671886, ss1752671887, ss1917824218, ss1928221182, ss1946224983, ss1959065739, ss1966656833, ss2024799568, ss2153023196, ss2634678732, ss2985425388, ss2986055656, ss3002295505, ss3022794952, ss3347917529, ss3629947394, ss3629947395, ss3632582026, ss3633482843, ss3634208721, ss3635148765, ss3635148766, ss3635888012, ss3636883641, ss3637641080, ss3638732243, ss3640856055, ss3640856056, ss3644958139, ss3646366472, ss3653331083, ss3654186853, ss3670034293, ss3735203030, ss3744575411, ss3745448704, ss3745448705, ss3767344120, ss3772941390, ss3772941391, ss3786002341, ss3791274270, ss3796154583, ss3824334073, ss3825732499, ss3830897642, ss3838949156, ss3868724860, ss3916116988, ss3984386891, ss3984386892, ss3984597499, ss3986407667, ss5186284180, ss5237432073, ss5315289674, ss5377761595, ss5509184676, ss5624173709, ss5624679174, ss5644299745, ss5799741007, ss5800058738, ss5800143744, ss5823734831, ss5848697353, ss5973500221, ss5979846286, ss5980471971 | NC_000007.13:150645533:T:G | NC_000007.14:150948445:T:G | (self) |
RCV000058152.13, RCV000171815.3, RCV000223864.13, RCV000249181.2, RCV000276195.6, RCV001095232.5, RCV001841716.2, 52242564, 281082192, 3523338, 630074, 12083, 61338230, 606352934, 10051261921, ss487104648, ss2299064995, ss3026188806, ss3720992422, ss3726494921, ss3771408605, ss3810512819, ss3844406742, ss3962873600, ss4175774869, ss4768975375, ss5237039071, ss5237199192, ss5237650421, ss5275288308, ss5314421791, ss5472099033, ss5564716629, ss5727501126, ss5809231947, ss5856157498, ss5861489259 | NC_000007.14:150948445:T:G | NC_000007.14:150948445:T:G | (self) |
ss76900126 | NT_007914.14:11221549:T:G | NC_000007.14:150948445:T:G | (self) |
ss4181602, ss9807249, ss69364196, ss74912009, ss119404135, ss153737242, ss159329902, ss160463284, ss172926528, ss244285189, ss410872566 | NT_007914.15:11241156:T:G | NC_000007.14:150948445:T:G | (self) |
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
PMID | Title | Author | Year | Journal |
---|---|---|---|---|
14760 | Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings]. | Cambridge D et al. | 1977 | British journal of pharmacology |
10807545 | Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population. | Iwasa H et al. | 2000 | Journal of human genetics |
11997281 | Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. | Yang P et al. | 2002 | Circulation |
12402336 | DHPLC analysis of potassium ion channel genes in congenital long QT syndrome. | Jongbloed R et al. | 2002 | Human mutation |
12829173 | A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. | Bezzina CR et al. | 2003 | Cardiovascular research |
14661677 | Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. | Ackerman MJ et al. | 2003 | Mayo Clinic proceedings |
14760488 | Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. | Paulussen AD et al. | 2004 | Journal of molecular medicine (Berlin, Germany) |
15599693 | Single nucleotide polymorphism map of five long-QT genes. | Aydin A et al. | 2005 | Journal of molecular medicine (Berlin, Germany) |
15746444 | Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. | Pfeufer A et al. | 2005 | Circulation research |
16116052 | KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. | Crotti L et al. | 2005 | Circulation |
16132053 | Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. | Gouas L et al. | 2005 | European journal of human genetics |
16487223 | Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore. | Koo SH et al. | 2006 | British journal of clinical pharmacology |
17161064 | Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes. | Mank-Seymour AR et al. | 2006 | American heart journal |
17210839 | Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. | Arnestad M et al. | 2007 | Circulation |
17227789 | The common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: results from the KORA study. | Akyol M et al. | 2007 | European heart journal |
17534376 | Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. | Gouas L et al. | 2007 | European journal of human genetics |
17709632 | Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. | Newton-Cheh C et al. | 2007 | Circulation |
18060054 | A novel and lethal de novo LQT-3 mutation in a newborn with distinct molecular pharmacology and therapeutic response. | Bankston JR et al. | 2007 | PloS one |
18222980 | The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). | Sinner MF et al. | 2008 | European heart journal |
18785031 | Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study. | Raitakari OT et al. | 2009 | Annals of medicine |
18808722 | Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations. | Zhang X et al. | 2008 | BMC medical genetics |
19019189 | Common candidate gene variants are associated with QT interval duration in the general population. | Marjamaa A et al. | 2009 | Journal of internal medicine |
19149796 | Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study. | Lehtinen AB et al. | 2009 | Annals of noninvasive electrocardiology |
19214780 | In silico investigations on functional and haplotype tag SNPs associated with congenital long QT syndromes (LQTSs). | Sudandiradoss C et al. | 2008 | Genomic medicine |
19305408 | Common variants at ten loci influence QT interval duration in the QTGEN Study. | Newton-Cheh C et al. | 2009 | Nature genetics |
19305409 | Common variants at ten loci modulate the QT interval duration in the QTSCD Study. | Pfeufer A et al. | 2009 | Nature genetics |
19841300 | Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. | Kapa S et al. | 2009 | Circulation |
19995808 | PhosSNP for systematic analysis of genetic polymorphisms that influence protein phosphorylation. | Ren J et al. | 2010 | Molecular & cellular proteomics |
20215044 | Relationship of common candidate gene variants to electrocardiographic T-wave peak to T-wave end interval and T-wave morphology parameters. | Porthan K et al. | 2010 | Heart rhythm |
20400777 | Common variants in cardiac ion channel genes are associated with sudden cardiac death. | Albert CM et al. | 2010 | Circulation. Arrhythmia and electrophysiology |
20507645 | Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study. | Atalar F et al. | 2010 | Behavioral and brain functions |
20850564 | R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation. | Bartos DC et al. | 2011 | Heart rhythm |
21056700 | Lack of replication in polymorphisms reported to be associated with atrial fibrillation. | Sinner MF et al. | 2011 | Heart rhythm |
21511878 | Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study. | Noseworthy PA et al. | 2011 | Circulation. Cardiovascular genetics |
22581653 | Paralogous annotation of disease-causing variants in long QT syndrome genes. | Ware JS et al. | 2012 | Human mutation |
22688145 | Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters. | Parkman HP et al. | 2012 | Journal of clinical gastroenterology |
22690879 | Genetic polymorphisms for estimating risk of atrial fibrillation: a literature-based meta-analysis. | Smith JG et al. | 2012 | Journal of internal medicine |
23753525 | Long QT syndrome: beyond the causal mutation. | Amin AS et al. | 2013 | The Journal of physiology |
23820649 | Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. | Cooper DN et al. | 2013 | Human genetics |
23856471 | Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. | Duchatelet S et al. | 2013 | Circulation. Cardiovascular genetics |
23861362 | Interpreting secondary cardiac disease variants in an exome cohort. | Ng D et al. | 2013 | Circulation. Cardiovascular genetics |
24033266 | A systematic approach to assessing the clinical significance of genetic variants. | Duzkale H et al. | 2013 | Clinical genetics |
24705329 | Single-nucleotide variations in cardiac arrhythmias: prospects for genomics and proteomics based biomarker discovery and diagnostics. | Abunimer A et al. | 2014 | Genes |
25741868 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Richards S et al. | 2015 | Genetics in medicine |
29548277 | Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses. | Engelbrechtsen L et al. | 2018 | BMC genetics |
29623639 | Pharmacogenetics of Opioid Use Disorder Treatment. | Crist RC et al. | 2018 | CNS drugs |
33875422 | Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment. | Pernaute-Lau L et al. | 2021 | Antimicrobial agents and chemotherapy |
34638656 | Towards Understanding the Genetic Nature of Vasovagal Syncope. | Matveeva N et al. | 2021 | International journal of molecular sciences |
34919578 | In vivo identification and validation of novel potential predictors for human cardiovascular diseases. | Hammouda OT et al. | 2021 | PloS one |
35146537 | Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research. | Yang S et al. | 2022 | Molecular genetics and genomics |
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.